Hormones provide acute and long-term regulation of complex metabolic processes such as gluconeogenesis and glycolysis. The long term changes are generally the result of alterations of the amount of critical enzymes. The rate of synthesis of an enzyme is generally related to the amount of cytoplasmic mRNA, and the steady level of mRNA is determined by its rate of synthesis and degradation. The objectives of my research program are to understand how several hormones, each with a unique mechanism of action, combine to regulate gene expression and mRNA metabolism. We are also interested in learning how a single hormone can have opposing effects on genes in the same cell. Transcriptional regulation is achieved by the interaction of trans-acting protein factors which are targeted to the transcription complex by their respective cis-acting DNA elements. Hormones modulate this interaction and thereby influence transcription in a positive or negative direction. Our studies emphasize the regulation of the P-enolpyruvate carboxykinaae (PEPCK) gene which directs the synthesis of PEPCK, the rate-controlling enzyme in gluconeogenesis. The PEPCK gene is regulated positively by glucocorticoids and cAMP, and negatively by insulin. The regulation of gene transcription by insulin is a major emphasis of the laboratory so we also study gene 33 (which encodes a protein of unknown function) because it is positively regulated by insulin.
Three Specific Aims, each based on observations made during the current project period, are proposed.
Aim 1 : """"""""How does cAMP regulate PEPCK gene transcription?"""""""" concerns the purification and cloning of the trans-acting factor involved in this action of cAMP, and studies of the mechanism of action of the protein.
Aim 2 : """"""""How do glucocorticoids regulate mRNAPEPCK metabolism?"""""""" concerns the structure of the DNA element (and possible accessory protein factors) involved in the action of glucocorticoids on the PEPCK gene, and with the mechanism of mRNAPEPCK stabilization by glucocorticoids.
Aim 3 : """"""""How does insulin affect gene transcription?"""""""" concerns the identification of the insulin-responsive DNA elements in the PEPCK and gene 33 promoters; the identification, isolation and mechanism of action of the protein factors that bind to these elements will be explored.
These Aims will employ many techniques of contemporary molecular biology including: DNA-mediated transfection, mobility shift and footprinting assays to detect DNA-protein interactions, and in vitro transcription. The studies proposed address questions that have not been answered in any other system, so should provide new information.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DK035107-10
Application #
3483679
Study Section
Endocrinology Study Section (END)
Project Start
1984-07-01
Project End
1994-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
10
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Hall, Robert K; Wang, Xiaohui L; George, Leena et al. (2007) Insulin represses phosphoenolpyruvate carboxykinase gene transcription by causing the rapid disruption of an active transcription complex: a potential epigenetic effect. Mol Endocrinol 21:550-63
Herzog, Birger; Cardenas, Jessica; Hall, Robert K et al. (2006) Estrogen-related receptor alpha is a repressor of phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem 281:99-106
Herzog, Birger; Hall, Robert K; Wang, Xiaohui L et al. (2004) Peroxisome proliferator-activated receptor gamma coactivator-1alpha, as a transcription amplifier, is not essential for basal and hormone-induced phosphoenolpyruvate carboxykinase gene expression. Mol Endocrinol 18:807-19
Wang, Xiaohui L; Herzog, Birger; Waltner-Law, Mary et al. (2004) The synergistic effect of dexamethasone and all-trans-retinoic acid on hepatic phosphoenolpyruvate carboxykinase gene expression involves the coactivator p300. J Biol Chem 279:34191-200
Waltner-Law, Mary; Duong, David T; Daniels, Marc C et al. (2003) Elements of the glucocorticoid and retinoic acid response units are involved in cAMP-mediated expression of the PEPCK gene. J Biol Chem 278:10427-35
Duong, David T; Waltner-Law, Mary E; Sears, Rosalie et al. (2002) Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 277:32234-42
Waltner-Law, Mary E; Wang, Xiaohui L; Law, Brian K et al. (2002) Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277:34933-40
Cusi, K J; Pratipanawatr, T; Koval, J et al. (2001) Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes. Metabolism 50:602-6
Stafford, J M; Waltner-Law, M; Granner, D K (2001) Role of accessory factors and steroid receptor coactivator 1 in the regulation of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. J Biol Chem 276:3811-9
Stafford, J M; Wilkinson, J C; Beechem, J M et al. (2001) Accessory factors facilitate the binding of glucocorticoid receptor to the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 276:39885-91

Showing the most recent 10 out of 80 publications